GB201202228D0 - Reversal of replicative senescence - Google Patents

Reversal of replicative senescence

Info

Publication number
GB201202228D0
GB201202228D0 GBGB1202228.1A GB201202228A GB201202228D0 GB 201202228 D0 GB201202228 D0 GB 201202228D0 GB 201202228 A GB201202228 A GB 201202228A GB 201202228 D0 GB201202228 D0 GB 201202228D0
Authority
GB
United Kingdom
Prior art keywords
reversal
replicative senescence
replicative
senescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1202228.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Priority to GBGB1202228.1A priority Critical patent/GB201202228D0/en
Publication of GB201202228D0 publication Critical patent/GB201202228D0/en
Priority to PCT/EP2013/052579 priority patent/WO2013117713A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1202228.1A 2012-02-08 2012-02-08 Reversal of replicative senescence Ceased GB201202228D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1202228.1A GB201202228D0 (en) 2012-02-08 2012-02-08 Reversal of replicative senescence
PCT/EP2013/052579 WO2013117713A1 (en) 2012-02-08 2013-02-08 Reversal of senescence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1202228.1A GB201202228D0 (en) 2012-02-08 2012-02-08 Reversal of replicative senescence

Publications (1)

Publication Number Publication Date
GB201202228D0 true GB201202228D0 (en) 2012-03-28

Family

ID=45929857

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1202228.1A Ceased GB201202228D0 (en) 2012-02-08 2012-02-08 Reversal of replicative senescence

Country Status (2)

Country Link
GB (1) GB201202228D0 (en)
WO (1) WO2013117713A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2659845B1 (en) * 2016-09-19 2019-01-04 Univ Valencia Modulation of microRNAs against myotonic dystrophy type 1 and antagonists of microRNAs for this
WO2018093919A1 (en) * 2016-11-15 2018-05-24 City Of Hope Methods for intracellular delivery and enhanced gene targeting
KR102208777B1 (en) * 2017-09-26 2021-01-28 기초과학연구원 Composition comprising inhibitors of miR-210 for inhibiting age-related metabolic disease and its screening method
CN110205366B (en) * 2018-02-28 2022-06-21 伽蓝（集团）股份有限公司 Method for screening endogenous aging target of skin, active substance for improving endogenous aging of skin and screening method thereof
KR102163693B1 (en) * 2018-09-27 2020-10-12 차의과학대학교 산학협력단 Biomarker for senescence and anti-senescence and use thereof
CN112972494B (en) * 2019-12-16 2023-03-17 多能干细胞再生医学科技（广州）有限公司 Stem cell preparation for treating premature ovarian failure and application and preparation method thereof
CN113088485B (en) * 2021-05-13 2024-04-05 中国水产科学研究院黑龙江水产研究所 In-vitro culture method for zebra fish osteoblasts

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002530436A (en) * 1998-11-25 2002-09-17 ジェネティカ インコーポレイテッド Method and reagent for enhancing proliferation ability and preventing replication senescence
US20060188507A1 (en) * 2005-02-11 2006-08-24 Elias Georges Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors
WO2006097725A2 (en) 2005-03-15 2006-09-21 Queen Mary & Westfield College Pharmaceutical compositions comprising microparticles for delivery into neurons
US20090220465A1 (en) * 2005-11-07 2009-09-03 The General Hospital Corporation Methods and compositions for modulation of stem cell aging
US20080187917A1 (en) * 2006-02-22 2008-08-07 The Regents Of The University Of Michigan Compositions and methods for repressing the Ink4a and Arf senescence pathways
US20110052676A1 (en) 2009-09-01 2011-03-03 James Vincent Gruber Composition For Delaying Cellular Senescence
JP5671791B2 (en) * 2009-09-04 2015-02-18 ニプロ株式会社 Method for culturing proximal tubular epithelial cells (RPTEC)

Also Published As

Publication number Publication date
WO2013117713A1 (en) 2013-08-15

Similar Documents

Publication Publication Date Title
HRP20181628T1 (en) Compounds and their methods of use
HK1208439A1 (en) 5-azaindazole compounds and methods of use 5-
HK1212701A1 (en) Formulations of enzalutamide
ZA201502503B (en) Hppd variants and methods of use
EP2912178A4 (en) Super-enhancers and methods of use thereof
SG11201501499SA (en) Multi-functional compositions and methods of use
ZA201406082B (en) Use of ccr3-inhibitors
EP2852397A4 (en) Huwentoxin-iv variants and methods of use
GB201202228D0 (en) Reversal of replicative senescence
IL236312A0 (en) Preparation of 18f-fluciclovine
EP2881113A4 (en) New application of pogostone
PL2674155T3 (en) Association of resveratrol and carboxymethylglucan
EP2906576A4 (en) Glycosphingolipids and methods of use thereof
EP2892529A4 (en) Uses of (-)-perhexiline
IL239245A0 (en) New use of aclidinium
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
EP2924046A4 (en) Novel complex and use of same
GB201116105D0 (en) Compounds and methods for the reversal of replicative senescence
HK1212998A1 (en) Ron compositions and methods of use thereof ron
GB201217666D0 (en) Construction of surfaces
TWM433525U (en) Structure of calorifier
EP2841164A4 (en) Dermal-appropriate compositions and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)